Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.27
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
0.78
Today|||52-Week Range
1.88
+28.40%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.27
Today’s openn.a.
Day’s range1.17 - 1.27
Volume1,518
Average volume (3 months)2,941,731
Market cap$53.0M
Dividend yield--
Data as of 07/01/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio2.0
Price/Sales1.55
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...+0.23+9.70%
EBIOEleven Biotherapeuti...+0.02+0.71%
HTBXHeat Biologics Inc0.000.00%
OGXIOncoGenex Pharmaceut...0.000.00%
Data as of 07/01/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers